NMDAR encephalitis: passive transfer from man to mouse by a recombinant antibody

Annals of Clinical and Translational Neurology

Volumn 4, Issue 11, 2017, Pages 768-783

  Malviya, Manish ^a,j   Barman, Sumanta ^a   Golombeck, Kristin S ^b   Planagumà, Jesús ^c   Mannara, Francesco ^c,d   Strutz Seebohm, Nathalie ^b   Wrzos, Claudia ^e   Demir, Fatih ^a,k   Baksmeier, Christine ^a   Steckel, Julia ^a   Falk, Kim Kristin ^f   Gross, Catharina C ^b   Kovac, Stjepana ^b   Bönte, Kathrin ^b   Johnen, Andreas ^b   Wandinger, Klaus Peter ^f   Martín García, Elena ^d   Becker, Albert J ^g   Elger, Christian E ^g   Klöcker, Nikolaj ^a   Wiendl, Heinz ^b   Meuth, Sven G ^b   Hartung, Hans Peter ^a   Seebohm, Guiscard ^b   Leypoldt, Frank ^f   Maldonado, Rafael ^d   Stadelmann, Christine ^e   Dalmau, Josep ^c,h,i   Melzer, Nico ^b   Goebels, Norbert ^a   more..

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c UNIVERSITY OF BARCELONA   (Spain)

^d UNIVERSITAT POMPEU FABRA   (Spain)

^e UNIVERSITY OF GÖTTINGEN   (Germany)

^f UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^g UNIVERSITY OF BONN   (Germany)

^h INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

ⁱ UNIVERSITY OF PENNSYLVANIA   (United States)

^j University of Toulouse III   (France)

^k FORSCHUNGSZENTRUM JÜLICH   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT ANTIBODY;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTI N METHYL D ASPARTATE RECEPTOR ENCEPHALITIS; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CRYOPRESERVATION; FEMALE; FLOW CYTOMETRY; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOTHERAPY; MOLECULAR CLONING; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VOLTAGE CLAMP TECHNIQUE; XENOPUS LAEVIS;

EID: 85033694858     PISSN: None     EISSN: 23289503     Source Type: Journal    
DOI: 10.1002/acn3.444     Document Type: Article

References (34)

1. Dalmau J, Gleichman AJ, Hughes EG, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 2008;7:1091–1098.
2. Titulaer MJ, McCracken L, Gabilondo I, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 2013;12:157–165.
3. Pruss H, Finke C, Holtje M, et al. N-methyl-D-aspartate receptor antibodies in herpes simplex encephalitis. Ann Neurol 2012;72:902–911.
4. Armangue T, Leypoldt F, Malaga I, et al. Herpes simplex virus encephalitis is a trigger of brain autoimmunity. Ann Neurol 2014;75:317–323.
5. Gresa-Arribas N, Titulaer MJ, Torrents A, et al. Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study. Lancet Neurol 2014;13:167–177.
6. Camdessanché J-P, Streichenberger N, Cavillon G, et al. Brain immunohistopathological study in a patient with anti-NMDAR encephalitis. Eur J Neurol 2011;18:929–931.
7. Martinez-Hernandez E, Horvath J, Shiloh-Malawsky Y, et al. Analysis of complement and plasma cells in the brain of patients with anti-NMDAR encephalitis. Neurology 2011;77:589–593.
8. Moscato EH, Peng X, Jain A, et al. Acute mechanisms underlying antibody effects in anti-N-methyl-D-aspartate receptor encephalitis. Ann Neurol 2014;76:108–119.
9. Hughes EG, Peng X, Gleichman AJ, et al. Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis. J Neurosci 2010;30:5866–5875.
10. Mikasova L, De Rossi P, Bouchet D, et al. Disrupted surface cross-talk between NMDA and Ephrin-B2 receptors in anti-NMDA encephalitis. Brain 2012;135(Pt 5):1606–1621.
11. Planagumà J, Haselmann H, Mannara F, et al. Ephrin-B2 prevents N-methyl-D-aspartate receptor antibody effects on memory and neuroplasticity. Ann Neurol 2016;80:388–400.
12. Vitureira N, Letellier M, Goda Y. Homeostatic synaptic plasticity: from single synapses to neural circuits. Curr Opin Neurobiol 2012;22:516–521.
13. Bien CG, Vincent A, Barnett MH, et al. Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis. Brain 2012;135(Pt 5):1622–1638.
14. Dalmau J, Tüzün E, H-y W, et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 2007;61:25–36.
15. Planagumà J, Leypoldt F, Mannara F, et al. Human N-methyl D-aspartate receptor antibodies alter memory and behaviour in mice. Brain 2015;138(Pt 1):94–109.
16. Dalmau J. NMDA receptor encephalitis and other antibody-mediated disorders of the synapse: The 2016 Cotzias Lecture. Neurology 2016;87:2471–2482.
17. Kreye J, Wenke NK, Chayka M, et al. Human cerebrospinal fluid monoclonal N-methyl-D-aspartate receptor autoantibodies are sufficient for encephalitis pathogenesis. Brain 2016;139(Pt 10):2641–2652.
18. Obermeier B, Mentele R, Malotka J, et al. Matching of oligoclonal immunoglobulin transcriptomes and proteomes of cerebrospinal fluid in multiple sclerosis. Nat Med 2008;14:688–693.
19. von Büdingen H-C, Harrer MD, Kuenzle S, et al. Clonally expanded plasma cells in the cerebrospinal fluid of MS patients produce myelin-specific antibodies. Eur J Immunol 2008;38:2014–2023.
20. Golombeck KS, Bönte K, Mönig C, et al. Evidence of a pathogenic role for CD8(+) T cells in anti-GABAB receptor limbic encephalitis. Neurol Neuroimmunol Neuroinflamm 2016;3:e232.
21. Kuenzle S, von Büdingen H-C, Meier M, et al. Pathogen specificity and autoimmunity are distinct features of antigen-driven immune responses in neuroborreliosis. Infect Immun 2007;75:3842–3847.
22. Tiller T, Meffre E, Yurasov S, et al. Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning. J Immunol Methods 2008;329(1–2):112–124.
23. Saitou N, Nei M. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 1987;4:406–425.
24. Hillis DM, Bull JJ, White ME, et al. Experimental phylogenetics: generation of a known phylogeny. Science 1992;255:589–592.
25. Raymond C, Tom R, Perret S, et al. A simplified polyethylenimine-mediated transfection process for large-scale and high-throughput applications. Methods 2011;55:44–51.
26. Lai M, Hughes EG, Peng X, et al. AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol 2009;65:424–434.
27. Petit-Pedrol M, Armangue T, Peng X, et al. Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies. Lancet Neurol 2014;13:276–86.
28. Seebohm G, Chen J, Strutz N, et al. Molecular determinants of KCNQ1 channel block by a benzodiazepine. Mol Pharmacol 2003;64:70–77.
29. Gleichman AJ, Spruce LA, Dalmau J, et al. Anti-NMDA receptor encephalitis antibody binding is dependent on amino acid identity of a small region within the GluN1 amino terminal domain. J Neurosci 2012;32:11082–11094.
30. Kayser MS, Kohler CG, Dalmau J. Psychiatric manifestations of paraneoplastic disorders. Am J Psychiatry 2010;167:1039–1050.
31. Kayser MS, Dalmau J. Anti-NMDA receptor encephalitis, autoimmunity, and psychosis. Schizophr Res 2016;176:36–40.
32. Masdeu JC, Dalmau J, Berman KF. NMDA Receptor Internalization by Autoantibodies: a Reversible Mechanism Underlying Psychosis? Trends Neurosci 2016;39:300–310.
33. Castillo-Gomez E, Oliveira B, Tapken D, et al. All naturally occurring autoantibodies against the NMDA receptor subunit NR1 have pathogenic potential irrespective of epitope and immunoglobulin class. Mol Psychiatry, advance online publication, 9 August 2016; doi:10.1038/mp.2016.125
34. Levitan IB. It is calmodulin after all! Mediator of the calcium modulation of multiple ion channels. Neuron 1999;22:645–648.